"Ganoderma lucidum reduces obesity in mice by modulating the compositio" by Chih-Jung Chang, Chuan-Sheng Lin et al.
 

ORCiD

David M. Ojcius: 0000-0003-1461-4495

Department

Biomedical Sciences

Document Type

Article

Publication Title

Nature Communications

ISSN

2041-1723

Volume

6

DOI

10.1038/ncomms8489

First Page

1

Last Page

17

Publication Date

6-23-2015

Abstract

Obesity is associated with low-grade chronic inflammation and intestinal dysbiosis. Ganoderma lucidum is a medicinal mushroom used in traditional Chinese medicine with putative anti-diabetic effects. Here, we show that a water extract of Ganoderma lucidum mycelium (WEGL) reduces body weight, inflammation and insulin resistance in mice fed a high-fat diet (HFD). Our data indicate that WEGL not only reverses HFD-induced gut dysbiosis—as indicated by the decreased Firmicutes-to-Bacteroidetes ratios and endotoxin-bearing Proteobacteria levels—but also maintains intestinal barrier integrity and reduces metabolic endotoxemia. The anti-obesity and microbiota-modulating effects are transmissible via horizontal faeces transfer from WEGL-treated mice to HFD-fed mice. We further show that high molecular weight polysaccharides (>300 kDa) isolated from the WEGL extract produce similar anti-obesity and microbiota-modulating effects. Our results indicate that G. lucidum and its high molecular weight polysaccharides may be used as prebiotic agents to prevent gut dysbiosis and obesity-related metabolic disorders in obese individuals.

Comments

Article number: 7489

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 1079
    • Patent Family Citations: 3
  • Usage
    • Downloads: 158
    • Abstract Views: 44
  • Captures
    • Readers: 565
  • Mentions
    • Blog Mentions: 5
    • News Mentions: 12
  • Social Media
    • Shares, Likes & Comments: 705
see details

Share

COinS